ResearcherNavarre Institute of Health ResearchActive in the last 2 years
Antonio Viúdez
Matched on ORCID iD 0000-0001-8810-6851; OpenAlex author ID A5088309104. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 3, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 2 papers
Papers 6
- Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets. Co-author DOI 10.1002/1878-0261.13658↗
- Building on the clinical applicability of ctDNA analysis in non-metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-024-67235-y↗
- Cytokines and Lymphoid Populations as Potential Biomarkers in Locally and Borderline Pancreatic Adenocarcinoma. First author DOI 10.3390/cancers14235993↗
- Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3389/fmed.2021.720128↗
- Omics Approaches in Pancreatic Adenocarcinoma. First author DOI 10.3390/cancers11081052↗
- Stellate cells, a point of light in the dark night of pancreatic cancer. First author DOI 10.1038/bjc.2014.59↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Iranzu González‐Borja · 5 shared papers, 2019–2024 · strength 0.65
- Paper Building on the clinical applicability of ctDNA analysis in non-metastatic pancreatic ductal adenocarcinoma. DOI 10.1038/s41598-024-67235-y↗
- Paper Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable … DOI 10.1002/1878-0261.13658↗
- Paper Cytokines and Lymphoid Populations as Potential Biomarkers in Locally and Borderline Pancreatic Adenocarcinoma. DOI 10.3390/cancers14235993↗
- Emilia Alors‐Pérez · 3 shared papers, 2021–2024 · strength 0.39
- Paper Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable … DOI 10.1002/1878-0261.13658↗
- Paper Cytokines and Lymphoid Populations as Potential Biomarkers in Locally and Borderline Pancreatic Adenocarcinoma. DOI 10.3390/cancers14235993↗
- Paper Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma. DOI 10.3389/fmed.2021.720128↗
- Justo Pastor Castano · 3 shared papers, 2021–2024 · strength 0.39
- Paper Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable … DOI 10.1002/1878-0261.13658↗
- Paper Cytokines and Lymphoid Populations as Potential Biomarkers in Locally and Borderline Pancreatic Adenocarcinoma. DOI 10.3390/cancers14235993↗
- Paper Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma. DOI 10.3389/fmed.2021.720128↗
- Ruth Vera · 4 shared papers, 2014–2022 · strength 0.35
- Paper Cytokines and Lymphoid Populations as Potential Biomarkers in Locally and Borderline Pancreatic Adenocarcinoma. DOI 10.3390/cancers14235993↗
- Paper Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma. DOI 10.3389/fmed.2021.720128↗
- Paper Omics Approaches in Pancreatic Adenocarcinoma. DOI 10.3390/cancers11081052↗
- Joaquín Fernández‐Irigoyen · 3 shared papers, 2019–2022 · strength 0.31
- Paper Cytokines and Lymphoid Populations as Potential Biomarkers in Locally and Borderline Pancreatic Adenocarcinoma. DOI 10.3390/cancers14235993↗
- Paper Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma. DOI 10.3389/fmed.2021.720128↗
- Paper Omics Approaches in Pancreatic Adenocarcinoma. DOI 10.3390/cancers11081052↗
- Hugo Arasanz Esteban · 1 shared paper, 2024 · strength 0.17
- Ibone Labiano · 1 shared paper, 2024 · strength 0.17
- Ruth Vera García · 1 shared paper, 2024 · strength 0.17
- Andrea Mafficini · 1 shared paper, 2024 · strength 0.16
- Ricardo Blázquez‐Encinas · 1 shared paper, 2024 · strength 0.16
- Rita Teresa Lawlor · 1 shared paper, 2024 · strength 0.16
- Claudio Luchini · 1 shared paper, 2024 · strength 0.16
- Aldo Scarpa Scarpa · 1 shared paper, 2024 · strength 0.16
- Ismael Ghanem · 1 shared paper, 2022 · strength 0.13
- Roberto Pazo-Cid · 1 shared paper, 2022 · strength 0.13
- Javier Gallego-Plazas · 1 shared paper, 2022 · strength 0.13
- Jaime Feliú · 1 shared paper, 2022 · strength 0.13
- Pablo Sala Elarre · 1 shared paper, 2019 · strength 0.08
- Estefanía Carrasco‐García · 1 shared paper, 2019 · strength 0.08
- Natalia Ramírez · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.